“ «SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY”, Medicine, vol. 3, no. 2, pp. 38–42, Dec. 2022, doi: 10.26577/IAM.2022.v3.i2.08.